Krish S. Krishnan, Chairman and Chief Executive Officer, and Suma M. Krishnan, President of Research and Development, will highlight these updates and Krystal’s strategic vision in a presentation at ...

CARLSBAD, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, today announced select preliminary unaudited financial results for the fourth ...

The company’s fourth quarter and full-year 2025 financial and operational results are preliminary and are subject to the completion of the company’s 2025 audit. Audited full-year 2025 and unaudited ...

• Patient 1 of Cohort 1 has now completed the 24-month follow-up timepoint, and at month-24 post-treatment Patient 1 continued to demonstrate the powerful disease-modifying effects of BB-301, with ...

A new Consumer Analysis investigates the SleepZee Mouth Guard, examining the moldable anti-snoring device's published specifications, material composition claims, and company disclosure practices as ...

The phrases "best GLP-1 patch," "natural Ozempic alternative," and "berberine weight loss patch" are used in this report to reflect common consumer search behavior and category language. GLP-1 ...

Critical Clarification: This is ingredient-level research only. NutriDerma Guard as a finished commercial product has not been independently clinically studied in published peer-reviewed trials.

The phrase "anti-snoring mouthpiece vs nose strips" is used to reflect common consumer search behavior. This report does not rank products, recommend purchases, or predict individual outcomes. The ...

According to Health Journey, GLP-1 Booster is a dietary supplement containing a probiotic blend designed to support gut health. The company states that the product is manufactured in a GMP-certified ...

Under the agreement, Etienna Bio has obtained exclusive global rights to intellectual property covering human adipose-derived progenitor cells combined with an adipose-derived hydrogel matrix, ...

Transdermal berberine patches represent an emerging supplement format driven by consumer interest in convenience and non-pill delivery. While ingredient-level research on berberine and chromium exists ...

Strong balance sheet with cash, cash equivalents, and marketable securities of $208.9 million*, including proceeds from the equity financing, which is anticipated to close on January 13, 2026, and ...